Healthcare investment firm venBio Partners LLC raised $288 million from 22 LPs toward a $303 million venture fund, according to an SEC filing.
The target on venBio Global Strategic Fund II LP was increased from a March 2015 filing, which set a goal of $250 million for the fund.
VenBio, which has offices in San Francisco and New York, typically invests in clinical-stage life science companies with a therapeutic product. In addition to venture capital funds, the firm manages a long-short equity hedge fund.DON'T MISS OUT! Meet new and diverse managers in private equity, venture capital and real estate at the third Emerging Manager Connect East at New York City's Harvard Club. CLICK HERE FOR DETAILS!